Practice Test Geeks(CCDM) Certified Clinical Data Manager Practice Test
← All CCDM Flashcard Decks

Risk-Based Monitoring Flashcards

7 cards from real CCDM practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Risk-Based Monitoring flashcards as text

  1. Which of the following is an example of a critical-to-quality factor that RBM would prioritize?

    Answer: Accurate assessment of the primary endpoint

    Critical-to-quality factors are those essential to subject protection and reliability of the primary results, such as primary endpoint assessment.

  2. A site has a very low adverse event reporting rate compared with similar sites. What is the most plausible risk this KRI highlights?

    Answer: Under-reporting of adverse events

    A rate far below peers can indicate under-reporting, a patient safety and data integrity risk.

  3. What is the main role of the data manager in a remote or centralized monitoring model?

    Answer: Provide timely, clean, integrated data and reports that enable risk signal detection

    Data management supplies the integrated, timely data and listings that central monitors depend on.

  4. Which document should describe KRI thresholds, review frequency and escalation actions in an RBM study?

    Answer: Monitoring plan or risk management plan

    The monitoring plan or risk management plan documents the KRIs, thresholds, cadence and escalation steps.

  5. Targeted SDV differs from traditional 100% SDV mainly because it:

    Answer: Focuses verification on critical data and higher-risk sites or subjects

    Targeted SDV concentrates verification effort on critical data points and areas of elevated risk.

  6. A KRI threshold is set too tight, producing many false alerts at nearly every site. What is the best corrective step?

    Answer: Re-evaluate and recalibrate the threshold using observed data and document the change

    Thresholds should be recalibrated based on data and documented through change control so alerts stay meaningful.

  7. Which regulatory guidance explicitly encourages a risk-based approach to monitoring clinical investigations in the US?

    Answer: FDA guidance on Oversight of Clinical Investigations: A Risk-Based Approach to Monitoring

    FDA's 2013 guidance on a risk-based approach to monitoring supports centralized and targeted on-site monitoring.

How this page was made: written with AI tools and published by Nathan Beja, founder of Practice Test Geeks, who is responsible for its content. Exam facts are checked against the official sources listed below. Not reviewed by a subject-matter expert. Editorial policy

Sources & references

Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy

  1. scdm.org — Test delivery, eligibility, exam format, retake policy, score release, test dates, fees, retake fee, score validity · verified Nov 2026